Mylène Jansen

SF biomarker changes upon KJD 339 16 References 1. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: An update with relevance for clinical practice. The Lancet. 2011 Jun 18;377(9783):2115–26. 2. Brandt KD, Dieppe P, Radin EL. Commentary: Is it useful to subset “primary” osteoarthritis? A critique based on evidence regarding the etiopathogenesis of osteoarthritis. Seminars in Arthritis and Rheumatism. 2009 Oct;39(2):81–95. 3. Burleigh A, Chanalaris A, Gardiner MD, et al . Joint immobilization prevents murine osteoarthritis and reveals the highly mechanosensitive nature of protease expression in vivo. Arthritis and Rheumatism. 2012 Jul;64(7):2278–88. 4. Vincent TL, Wann AKT. Mechanoadaptation: Articular cartilage through thick and thin. Journal of Physiology. 2019 Mar;597(5):1271–81. 5. Benichou C, Wirotius JM. Articular cartilage atrophy in lower limb amputees. Arthritis and Rheumatism. 1982;25(1):80–2. 6. O’Neill TW, McCabe PS, McBeth J. Update on the epidemiology, risk factors and disease outcomes of osteoarthritis. Best Practice and Research: Clinical Rheumatology. 2018 Apr;32(2):312–26. 7. Nicholls E, Thomas E, van der Windt DA, et al . Pain trajectory groups in persons with, or at high risk of, knee osteoarthritis: Findings from the Knee clinical assessment study and the osteoarthritis initiative. Osteoarthritis and Cartilage. 2014;22(12):2041–50. 8. Callaghan MJ, Parkes MJ, Hutchinson CE, et al . A randomised trial of a brace for patellofemoral osteoarthritis targeting knee pain and bone marrow lesions. Annals of the Rheumatic Diseases. 2015 Jun 1;74(6):1164–70. 9. Dell’accio F, Vincent TL. Joint surface defects: Clinical course and cellular response in spontaneous and experimental lesions. European cells and Materials. 2010 Sep;20:210–7. 10. Parker DA, Beatty KT, Giuffre B, et al . Articular cartilage changes in patients with osteoarthritis after osteotomy. American Journal of Sports Medicine. 2011 May;39(5):1039–45. 11. Schreurs BW, Hannink G. Total joint arthroplasty in younger patients: Heading for trouble? The Lancet. 2017 Apr;389(10077):1374–5. 12. Struik T, Jaspers JEN, Besselink NJ, et al . Technical feasibility of personalized articulating knee joint distraction for treatment of tibiofemoral osteoarthritis. Clinical Biomechanics. 2017 Nov 1;49:40–7. 13. Marijnissen ACA, Hoekstra MCL, Pré BCD, et al . Patient characteristics as predictors of clinical outcome of distraction in treatment of severe ankle osteoarthritis. Journal of Orthopaedic Research. 2014 Jan;32(1):96– 101. 14. Wiegant K, van Roermund PM, Intema F, et al . Sustained clinical and structural benefit after joint distraction in the treatment of severe knee osteoarthritis. Osteoarthritis and Cartilage. 2013 Nov;21(11):1660–7. 15. van der Woude JAD, Wiegant K, van Roermund PM, et al . Five-year follow-up of knee joint distraction: Clinical benefit and cartilaginous tissue repair in an open uncontrolled prospective study. Cartilage. 2017;8(3):263–71. 16. JansenMP, van der Weiden GS, van Roermund PM, et al . Initial tissue repair predicts long-term clinical success of knee joint distraction as treatment for knee osteoarthritis. Osteoarthritis and Cartilage. 2018;26(12):1604– 8. 17. van der Woude JAD, van Heerwaarden RJ, Spruijt S, et al . Six weeks of continuous joint distraction appears sufficient for clinical benefit and cartilaginous tissue repair in the treatment of knee osteoarthritis. Knee. 2016 Oct 1;23(5):785–91. 18. Jansen MP, Besselink NJ, van Heerwaarden RJ, et al . Knee joint distraction compared with high tibial osteotomy and total knee arthroplasty: Two-year clinical, radiographic, and biochemical marker outcomes of